News

To meet the skin's changing needs over various life stages, experts at the Generational Dermatology Symposium held earlier this year suggest being proactive about barrier problems and that moisturization is key to maintaining skin health.

Researchers examine T. purpurea benefits for “well-aging” in mature population.

Adding PRP to a base serum designed to maintain the viability of platelet cells personalizes topical cosmetic products.

Psoriasis patients face a long list of comorbidities, increased medical costs and increased mortality. Experts agree that the burden of psoriasis is heavy - what can dermatologists do to offer relief?

How far can drug companies go with off-label promotion? Dr. Goldberg addresses this and more in his latest Legal Eagle column.

Gillette announced in July that a 12-week study shows its SkinGuard razor reduced incidence of pseudofolliculitis barbae papules in men by more than 61% at three months.

Patients on powerful immunocompromising agents might be predisposed to infections; however the potential association between biologic agents and increased risk isn’t necessarily universal, Whitney High, M.D., reported during the summer meeting of the American Academy of Dermatology.

Kimberly S. Salkey, M.D., shares answers to some of the most common questions she encounters from patients about OTC hair loss treatments.

From portable desks to bluetooth trackpads, this is the latest and greatest roundup of organizational must-haves for the busy dermatologist.

Farnesol, an alcohol found in essential oils including ambrette seed and citronella, could be a beneficial component of facial masks, according to a recent study.

Psoriasis does not appear to impact fertility, but there are conflicting data on whether psoriasis itself affects the risk of pregnancy complications in women of childbearing age. This expert weighs in on the subject.

About one-third of patients with psoriasis are children or adolescents. Still, little research exists on treating this patient population. New disease management guidelines and emerging studies seek to fill the gap.

Recognize whether the test being ordered is the right one for the condition suspected, as well as whether the patient’s insurance company will fund it, Jennifer Hand, M.D., told colleagues at the Society for Pediatric Dermatology Annual Meeting this weekend in Austin, Texas.

With the high incidence of psoriasis and psoriatic arthritis among patients who are obese, it’s important for dermatologists to address weight and weight management. But, having that conversation is not always easy. Dr. Soltani-Arabshahi offers tips to help you talk to your psoriasis patients about their weight.

Data shows obesity is prevalent among patients with psoriasis and psoriatic arthritis, but the exact role weight plays in contributing to psoriatic disease and its severity is still unknown. At a minimum, industry experts agree that addressing obesity can be vital in treating psoriatic disease.

Authors of a new anatomical gluteal fat grafting study report no subfascial or intramuscular injection should ever be performed.

Patients often don’t talk about the impact of genital psoriasis because of the stigmatization, feeling shy or fear of judgement. It's up to dermatologists to proactively ask patients about their symptoms, urges a recent review.

Do you recommend psychotherapy to your psoriasis patients? While there is a well-established connection between psoriasis and mental health, there is little data available on the impact of psychological interventions on psoriasis. These study authors look to fill that gap.

It’s no secret that antibiotics have been successful in controlling most acne cases, but the need to limit antibiotic use means acne treatment protocols are starting to shift. William James, M.D. emphasizes two alternatives dermatologists should turn to when treating patients with acne.

Inquiring minds at Cynosure wanted to know what inspires women to make a body change and surveyed 1,000 women in the UK to find out.

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Crisaborole ointment, 2%, (Eucrisa, Pfizer) appears to be safe and effective in children aged three months to less than 24 months who have mild-to-moderate atopic dermatitis, according to results of a phase 4 trial released yesterday.

As Dermatology Times celebrates 40 years of continuous publication, we asked Dr. Levine to share his thoughts on his years of contribution to the publication.

To celebrate the 40th Anniversary of Dermatology Times, we asked our Editorial Advisory Board members to reflect on the publication and how the practice of dermatology has changed over the past 40 years. In this article, Dr. Wheeland reviews his years of involvement with the Dermatology Times and what has happened in the dermatologic surgery world over those same years.

Pulsed dye laser (PDL) is widely accepted as the gold standard treatment of port-wine stains (PWS), but how early can you begin treating infants with PWS? According to this expert and a recent study, the sooner the better. 

Ortho Dermatologics announced that halobetasol propionate and tazarotene lotion, 0.01%/0.045% (Duobrii, Ortho Dermatologics) is now commercially available to healthcare providers, according to a press release issued June 25.